or Try an Advanced Search...

    Technical Analysis for BOLT - Bolt Biotherapeutics, Inc.

    Grade Last Price % Change Price Change
    F 0.73 -2.41% -0.02
    BOLT closed down 2.41 percent on Monday, July 1, 2024, on 73 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical BOLT trend table...
    Date Alert Name Type % Chg
    Bollinger Band Squeeze Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    BB Squeeze + Lower Band Touch Range Contraction 0.00%
    Gapped Down Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Bollinger Band Squeeze Range Contraction -2.41%
    Doji - Bearish? Reversal -2.41%
    Lower Bollinger Band Walk Weakness -2.41%
    Bollinger Band Squeeze Range Contraction -2.10%
    Older End-of-Day Signals for BOLT ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low about 8 hours ago
    60 Minute Opening Range Breakdown about 9 hours ago
    Down 2 % about 9 hours ago
    Gap Down Partially Closed about 10 hours ago
    Gapped Down (Partial) about 10 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    BOLT Chart by TradingView
    Basic chart:

    Profile

    Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, engages in the discovery, development, and commercialization of pharmaceutical products. The company develops BDC-1001, a human epidermal growth factor receptor 2 (HER2) for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors. Its preclinical stage product candidates include carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade; and myeloid modulators. Bolt Biotherapeutics, Inc. was founded in 2015 and is based Redwood city, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Clinical Medicine Pharmaceutical Products Tumor Cancer Immunotherapy Breast Cancer Immune Checkpoint Her2/Neu

    Is BOLT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 24 The Analyst Anxiety Index: 3 Stocks to Avoid as Uncertainty Grows
    May 18 Bolt Biotherapeutics, Inc. (BOLT) Q1 2024 Earnings Call Transcript
    May 15 Bolt Biotherapeutics Inc (BOLT) (Q1 2024) Earnings Call Transcript Highlights: Strategic Shifts ...
    May 15 Bolt Biotherapeutics GAAP EPS of -$0.28, revenue of $5.3M
    May 15 Bolt Biotherapeutics draws downgrades after portfolio shakeup
    May 15 Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
    May 15 Bolt Biotherapeutics to lay off staff, abandon lead ADC candidate
    May 14 Bolt Biotherapeutics Reports First Quarter 2024 Results, Announces Strategic Pipeline Prioritization and Changes to Leadership Team
    Apr 29 Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans?
    Mar 21 Bolt Biotherapeutics GAAP EPS of -$0.47 in-line, revenue of $2.1M beats by $0.31M
    See more BOLT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.56
    52 Week Low 0.7201
    Average Volume 256,275
    200-Day Moving Average 1.04
    50-Day Moving Average 0.90
    20-Day Moving Average 0.75
    10-Day Moving Average 0.74
    Average True Range 0.03
    RSI (14) 35.06
    ADX 29.76
    +DI 12.16
    -DI 22.28
    Chandelier Exit (Long, 3 ATRs) 0.70
    Chandelier Exit (Short, 3 ATRs) 0.82
    Upper Bollinger Bands 0.77
    Lower Bollinger Band 0.73
    Percent B (%b) 0.1
    BandWidth 6.18
    MACD Line -0.04
    MACD Signal Line -0.05
    MACD Histogram 0.0112
    Fundamentals Value
    Market Cap 27.79 Million
    Num Shares 38 Million
    EPS -1.89
    Price-to-Earnings (P/E) Ratio -0.39
    Price-to-Sales 5.68
    Price-to-Book 0.31
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.75
    Resistance 3 (R3) 0.75 0.75 0.75
    Resistance 2 (R2) 0.75 0.74 0.75 0.75
    Resistance 1 (R1) 0.74 0.74 0.74 0.74 0.75
    Pivot Point 0.73 0.73 0.73 0.73 0.73
    Support 1 (S1) 0.73 0.73 0.72 0.73 0.72
    Support 2 (S2) 0.72 0.72 0.72 0.72
    Support 3 (S3) 0.71 0.72 0.72
    Support 4 (S4) 0.71